Does DEFERASIROX Cause Myelofibrosis? 57 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Myelofibrosis have been filed in association with DEFERASIROX (Deferasirox). This represents 0.5% of all adverse event reports for DEFERASIROX.
57
Reports of Myelofibrosis with DEFERASIROX
0.5%
of all DEFERASIROX reports
33
Deaths
30
Hospitalizations
How Dangerous Is Myelofibrosis From DEFERASIROX?
Of the 57 reports, 33 (57.9%) resulted in death, 30 (52.6%) required hospitalization, and 13 (22.8%) were considered life-threatening.
Is Myelofibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEFERASIROX. However, 57 reports have been filed with the FAERS database.
What Other Side Effects Does DEFERASIROX Cause?
Death (1,583)
Diarrhoea (993)
Serum ferritin increased (732)
Haemoglobin decreased (615)
Pyrexia (607)
Malaise (605)
Nausea (603)
Sickle cell anaemia with crisis (570)
Vomiting (520)
Pneumonia (494)
What Other Drugs Cause Myelofibrosis?
RUXOLITINIB (1,316)
ELTROMBOPAG (89)
ROMIPLOSTIM (89)
HYDROXYUREA (88)
IMATINIB (76)
MOMELOTINIB (51)
ASPIRIN (46)
RITUXIMAB (43)
ANAGRELIDE (41)
ELTROMBOPAG OLAMINE (39)
Which DEFERASIROX Alternatives Have Lower Myelofibrosis Risk?
DEFERASIROX vs DEFERIPRONE
DEFERASIROX vs DEFEROXAMINE
DEFERASIROX vs DEFIBROTIDE
DEFERASIROX vs DEFLAZACORT
DEFERASIROX vs DEGARELIX